Equity Capital Markets

Company · CIK 1740547

Urovant Sciences Ltd.

CIK1740547 (SEC EDGAR)
Industry (SIC)2834 — Pharmaceutical Preparations
Incorporated inD0
Business addressCA
Listedno ticker on SEC record today
First annual or quarterly report2018-11-13

Offerings

2 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-234620
ShelfEffective
 2019-11-122021-03-313
333-226169
IPOFinal prospectus
 2018-07-132018-09-279

Filings

13
FiledFilingRegistrationAccession
2021-03-31EFFECTDeclared effective 333-2346209999999995-21-001220
2019-11-26EFFECTDeclared effective 333-2346209999999995-19-002675
2019-11-12S-3Shelf registered 333-2346200001193125-19-288620
2018-09-27424B4Final prospectus 333-2261690001193125-18-285778
2018-09-26EFFECTDeclared effective 333-2261699999999995-18-002461
2018-09-25S-1/AAmendment 333-2261690001193125-18-282188
2018-09-17S-1/AAmendment 333-2261690001193125-18-274614
2018-09-10S-1/AAmendment 333-2261690001193125-18-270163
2018-08-30S-1/AAmendment 333-2261690001193125-18-263665
2018-08-15S-1/AAmendment 333-2261690001193125-18-249832
2018-07-20S-1/AAmendment 333-2261690001193125-18-221855
2018-07-13S-1Registration filed 333-2261690001193125-18-217858
2018-05-23DRSDraft made public 377-020830000950123-18-005956

All filings of this company · CSV